News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Wellbeing Subsidiary KGK Science Announces AKL No Objection Status for ProGo® Branded Ingredient from FDA
Wellbeing Digital Sciences
MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder
Mind Medicine (MindMed)
Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson's Research for SLS-004
Seelos Therapeutics
Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment
Clearmind Medicine
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
Clearmind Medicine
Algernon Pharmaceuticals Announces Closing of Private Placement
Algernon Pharmaceuticals
Wellbeing Subsidiary IRP Health Toronto Location Approved by Veterans Affairs Canada for Its Reactivation Program
Wellbeing Digital Sciences
Algernon Pharmaceuticals’ Largest Shareholder AlphaNorth Asset Management Increases Ownership Position
Algernon Pharmaceuticals
PharmAla Biotech to supply Major Australian Research Institute with LaNeo™ MDMA for Phase 3 Clinical Trial
Pharmala Biotech Holdings
Core One Labs' Akome Achieves Another Milestone in Development of its Psychedelic Drug Formulas and Announces Positive Results from Neuro-Pharmacokinetics Studies
Core One Labs Inc.
Psychedelic Weekly Headlines | August 19th
Algernon Pharmaceuticals
Cybin Inc.
Field Trip Health
Optimi Health
Awakn Life Sciences
Universal Ibogaine Provides Update on Kelburn Recovery Center
Universal Ibogaine
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.